Migraine Trial, Recruiting (NCT06795867)

Migraine Trial, Recruiting NCT06795867 Sponsor: Brigham and Women's Hospital Condition: Migraine

Printed from Voxsanity (voxsanity.com.au) — NCT06795867 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Migraine

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing and able to take part in the consent process
You are willing to participate in the study, even if you are assigned to a group you didn't expect
You are available for the full length of the study
You have been diagnosed with chronic migraine and are being seen at the Graham Headache Center
You have access to the technology needed to take part in an online or app-based program (such as a smartphone or computer)

Who may not be able to join:

You have been diagnosed with major depression or another psychiatric (mental health) condition
You do not speak English
Your headaches have been diagnosed as caused by another underlying condition (rather than being a primary migraine diagnosis)
You have received any form of talking therapy (psychotherapy) in the last 18 months
Your doctor feels there is any reason you may have difficulty learning or practicing the type of therapy used in this study (confirm with trial site)
You have any previous experience with mindfulness or meditation practices

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 617 983 7580

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06795867

Sponsor: Brigham and Women's Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Migraine

Trial contact: 617 983 7580

More information: https://clinicaltrials.gov/study/NCT06795867

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing and able to take part in the consent process
You are willing to participate in the study, even if you are assigned to a group you didn't expect
You are available for the full length of the study
You have been diagnosed with chronic migraine and are being seen at the Graham Headache Center
You have access to the technology needed to take part in an online or app-based program (such as a smartphone or computer)

Who may not be able to join:

You have been diagnosed with major depression or another psychiatric (mental health) condition
You do not speak English
Your headaches have been diagnosed as caused by another underlying condition (rather than being a primary migraine diagnosis)
You have received any form of talking therapy (psychotherapy) in the last 18 months
Your doctor feels there is any reason you may have difficulty learning or practicing the type of therapy used in this study (confirm with trial site)
You have any previous experience with mindfulness or meditation practices

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Brigham and Women's Hospital

Registry

ClinicalTrials.gov

Start date

21 April 2025

Est. completion

1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Headache Disability Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov